Skip to main content

Alterations of the gene expression profile in renal cell carcinoma after treatment with the histone deacetylase-inhibitor valproic acid and interferon-alpha.

Juengel, E, Bhasin, M, Libermann, T, Barth, Susanne, Michaelis, Martin, Cinatl, Jindrich, Jones, J, Hudak, L, Jonas, Dietger, Blaheta, Roman A. and others. (2011) Alterations of the gene expression profile in renal cell carcinoma after treatment with the histone deacetylase-inhibitor valproic acid and interferon-alpha. World Journal of Urology, 29 (6). pp. 779-86. ISSN 1433-8726. (doi:10.1007/s00345-010-0582-y) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided. (Contact us about this Publication)
Official URL
http://dx.doi.org/10.1007/s00345-010-0582-y

Abstract

This data provides insight into the molecular mechanism of action of the combined treatment of VPA and IFN-alpha in RCC. Implications are that the combined application of VPA and IFN-alpha may represent a more efficient alternative to existing therapy options for RCC.

Item Type: Article
DOI/Identification number: 10.1007/s00345-010-0582-y
Subjects: R Medicine > RM Therapeutics. Pharmacology
Divisions: Faculties > Sciences > School of Biosciences
Depositing User: Martin Michaelis
Date Deposited: 05 Jun 2013 17:39 UTC
Last Modified: 29 May 2019 10:14 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/34067 (The current URI for this page, for reference purposes)
  • Depositors only (login required):